X-ray Device Makers In Japan Excluded From Bidding Due To Collusion
This article was originally published in PharmAsia News
Japan Fair Trade Commission finds that three X-ray device manufacturers have repeatedly been involved in collusive bidding for orders from public hospitals. JFTC has excluded two companies, Tokyo-based Toshiba Medical Systems and Kyodo-based Shimadzu Corporation, from future bidding for violating the anti-trust law. The commission also ordered fined Toshiba Medical Systems and Shimadzu ¥10 million and ¥6.2 million, respectively. The third company, Tokyo-based Hitachi Medical Corp. was not fined and also not excluded from future bidding because it reported the collusive bidding practice to authorities.The three companies account for 70 percent of the X-ray device market in Japan. (Click here for more - Japanese language
You may also be interested in...
Veklury is now the first US FDA-approved treatment for COVID-19, but its limited benefits means its lifespan as a blockbuster could be short.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
Phase II results look good for one of the first-in-class product’s potential indications, C3 glomerulopathy. The product was highlighted late last year as an up-and-coming pipeline asset.